Your Next Project Starts Here

Tell us a bit about your idea, and we’ll get back to you with a clear path forward.


How Startup Valuation Is Actually Calculated (And What Your Number Means)

As businesses rush to adopt AI in their marketing strategies, hidden biases in algorithms often go unnoticed.

Most founders learn their company’s “value” from a friend’s round or a number an investor floats in a meeting. Then diligence starts, someone asks where the number came from, and the whole thing falls apart.

Here is the uncomfortable truth: a startup valuation is not a fact you discover. It is a range you argue for, using methods everyone in the room recognises. The founders who raise well are not the ones with the highest number. They are the ones who can defend the number they have.

This is how that number actually gets built.

There is no single "value." There is a weighted range.

Serious valuations almost never rest on one method. They run several, then weight them by what fits your stage. A pre-revenue company and a company doing 5 crore in ARR get valued by completely different tools. Here are the ones that matter.

Discounted Cash Flow (DCF). You project the company’s future free cash flows, then discount them back to today using a rate that reflects the risk. Add a terminal value for everything beyond the forecast, and you have a present value. DCF is rigorous and forward-looking, but it is only as good as your assumptions, which is why it suits companies with real, forecastable cash flows more than a pre-revenue startup.

Comparables and multiples. You look at what similar companies are worth, usually as a multiple of revenue or EBITDA, and apply that multiple to your own numbers. This is fast and grounded in what the market is actually paying, but it lives or dies on whether your comparables are genuinely comparable, and on the same geography.

The VC Method. This is built for early-stage. You estimate what the company could exit for (say, exit-year revenue times an exit multiple), then work backwards using the return an investor needs, to arrive at a value today. It is the method that most closely mirrors how an early investor actually thinks.

Berkus and Scorecard methods. For pre-revenue startups with no cash flows to model, these assign value against qualitative factors: the strength of the idea, the prototype, the team, key relationships, and early traction (Berkus), or by benchmarking you against the average funded startup in your region and adjusting for team, market size, product, and competition (Scorecard).

Net asset value. Value the assets, subtract the liabilities. Useful for asset-heavy or winding-down businesses, close to useless for a growth startup whose value is its future, not its furniture.

How much is my startup worth before revenue?

This is the most searched valuation question there is, and the honest answer is: it depends on your team, your market, your traction, and comparable rounds, not on a formula. Pre-revenue companies are valued on potential and risk reduction, which is exactly what Berkus, Scorecard, and the VC Method are designed to capture. Anyone who gives you a precise pre-revenue number without asking about those things is guessing.

DCF or VC Method? A common point of confusion.

They answer different questions. DCF asks “what are this company’s future cash flows worth today?” The VC Method asks “what does this need to be worth today for me to hit my return at exit?” DCF is bottom-up from operations; the VC Method is top-down from an exit thesis. A good early-stage valuation often shows both, so it does not rest on a single lens.

What investors actually stress-test

When your valuation reaches a diligence team, they are not admiring the headline number. They are pulling on the assumptions: Are the comparables real and recent? Is the growth rate defensible? What happens to the number if you flex two or three key inputs? This is why a sensitivity analysis, showing how value moves as your assumptions move, is not a nice-to-have. It is the difference between a number that survives the room and one that does not.

Where this is heading: faster, harder diligence

The bar is rising because the tools have changed. A survey of nearly 300 private-capital dealmakers found 85% now use AI to automate daily tasks, up from 76% a year earlier. AI tools are cutting the time it takes to review contracts, financials, and growth metrics by roughly a third. Capital is also concentrating hard: AI-sector companies took about 80% of global venture funding in the first quarter of 2026, up from 55% a year earlier. EqvistaQubit Capital

For a founder, the takeaway is simple. Diligence is faster and more data-driven than it was even two years ago, which means a hand-wavy valuation gets caught faster, not slower. The winning move is not a bigger number. It is a number built on recognised methods, sourced inputs, and a visible sensitivity analysis, so that when someone pushes, it holds.

FAQ

Got Questions? We’ve Got Answers

By running several methods (DCF, comparables, the VC Method, and for early-stage, Berkus or Scorecard) and weighting them by what fits your stage, rather than relying on any single formula.

It depends on stage, traction, market, and comparable rounds. Get a fast estimate first, then a method-backed report for a number you can defend when an investor pushes.

DCF values you on discounted future cash flows. The VC Method works backwards from a target exit and required return. Early-stage valuations usually show both.

Building your number is where FinLensy starts: a free calculator for a fast, credible first figure, and an institutional report across eight methods, with a built-in sensitivity analysis, when the raise gets real.